Dr. Ronald Jubin, Ph.D.

rjubinDr. Jubin is Vice President of Research and Development at Prolong Pharmaceuticals and brings more than two decades of experience at the forefront of drug discovery. Ron’s experience includes key roles at Schering-Plough Research Institute and PBL Biomedical labs.

At Schering-Plough, Dr. Jubin served in major roles in the hepatitis C protease program, directed other HCV inhibitor programs, and managed internal committees evaluating licensing opportunities for a novel interferon candidate. At PBL Biomedical, his tenure leading the Research and Development department at PBL resulted in the development of numerous interferon proteins, reagents, and functional assay for evaluating immune and interferon functions. Dr. Jubin received his PhD in Microbiology and Molecular Genetics from the UMDNJ-NJMS Graduate School of Biomedical Sciences, Newark, NJ.